Mark L. Barr

9.3k total citations · 1 hit paper
137 papers, 6.2k citations indexed

About

Mark L. Barr is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark L. Barr has authored 137 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Surgery, 49 papers in Transplantation and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark L. Barr's work include Transplantation: Methods and Outcomes (68 papers), Organ Transplantation Techniques and Outcomes (40 papers) and Renal Transplantation Outcomes and Treatments (33 papers). Mark L. Barr is often cited by papers focused on Transplantation: Methods and Outcomes (68 papers), Organ Transplantation Techniques and Outcomes (40 papers) and Renal Transplantation Outcomes and Treatments (33 papers). Mark L. Barr collaborates with scholars based in United States, Canada and United Kingdom. Mark L. Barr's co-authors include Vaughn A. Starnes, Felicia A. Schenkel, Robbin G. Cohen, Rainer W.G. Gruessner, Winfield J. Wells, Alan B. Leichtman, Gordon D. Wu, Eric A. Rose, Rami Bustami and H.-U. Meier-Kriesche and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Mark L. Barr

134 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression: Evolution in Practice and Trends, 1994–2004

2006 434 citations Mark L. Barr et al. American Journal of Transplantation profile →

Peers

Countries citing papers authored by Mark L. Barr

Since Specialization

Citations

This map shows the geographic impact of Mark L. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Barr more than expected).

Fields of papers citing papers by Mark L. Barr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Barr. The network helps show where Mark L. Barr may publish in the future.

Co-authorship network of co-authors of Mark L. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Barr. A scholar is included among the top collaborators of Mark L. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Barr. Mark L. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of a Bluetooth tablet-based technology to improve outcomes in lung transplantation: A pilot study 2020 ·American Journal of Transplantation ·Felicia A. Schenkel, Mark L. Barr, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Amy Hackmann, Sivagini Ganesh	12
2	Takotsubo Cardiomyopathy in a Heart Transplant Recipient 2013 ·CHEST Journal ·(unknown), Sivagini Ganesh, Thomas Kleisli, Mark L. Barr	2
3	Alveolar inflammation in cystic fibrosis 2010 ·Journal of Cystic Fibrosis ·Martina Ulrich, Dieter Worlitzsch, Simona Viglio, (unknown), Paolo Iadarola, Janis K. Shute, Marianne Geiser, Gerald B. Pier, Godehard Friedel, Mark L. Barr, Antje Schuster, Keith C. Meyer, Félix Ratjen, Thomas Bjarnsholt, Erich Gulbins, Gerd Döring	95
4	Electrochemical Impedance Spectroscopy to Assess Vascular Oxidative Stress 2010 ·Annals of Biomedical Engineering ·Fei Yu, Rongsong Li, Lisong Ai, Collin Edington, Hongyu Yu, Mark L. Barr, (unknown), Tzung K. Hsiai	11
5	Outcomes after Lung Retransplantation in the Modern Era 2007 ·American Journal of Respiratory and Critical Care Medicine ·Steven M. Kawut, David J. Lederer, Shaf Keshavjee, Jessie S. Wilt, (unknown), F. D’Ovidio, Joshua Sonett, Selim M. Arcasoy, Mark L. Barr	86
6	Developments in Clinical Islet, Liver Thoracic, Kidney and Pancreas Transplantation in the Last 5 Years 2006 ·American Journal of Transplantation ·Sandy Feng, Mark L. Barr, John P. Roberts, Rainer Oberbauer, Bruce Kaplan	9
7	The Ethics of Living Donor Lung Transplantation 2005 ·Thoracic surgery clinics/Thorac. surg. clin. ·Winfield J. Wells, Mark L. Barr	2
8	Thoracic organ transplantation in the United States, 1994–2003 2005 ·American Journal of Transplantation ·Mark L. Barr, Robert C. Bourge, Jonathan B. Orens, Kenneth R. McCurry, W. Steves Ring, Tempie E. Hulbert‐Shearon, Robert M. Merion	32
9	Transforming Growth Factor-β/Interleukin-2–induced Regulatory CD4+ T Cells Prolong Cardiac Allograft Survival in Rats 2005 ·The Journal of Heart and Lung Transplantation ·(unknown), (unknown), Donald V. Cramer, Vaughn A. Starnes, Mark L. Barr	9
10	Potential role for antiangiogenic proteins in the myocardial infarction repair process 2004 ·Journal of Surgical Research ·Jess L. Thompson, James A. Ryan, Mark L. Barr, Benjamin L. Franc, Vaughn A. Starnes, Margaret A. Schwarz	9
11	A Decade of Living Lobar Lung Transplantation: Perioperative Complications after 253 Donor Lobectomies 2004 ·American Journal of Transplantation ·Michael E. Bowdish, Mark L. Barr, Felicia A. Schenkel, Marlyn S. Woo, Ross M. Bremner, Monica V. Horn, Craig Baker, Richard G. Barbers, Winfield J. Wells, Vaughn A. Starnes	42
12	Living donor lung transplantation: selection, technique, and outcome 2001 ·Transplantation Proceedings ·Mark L. Barr, Craig Baker, Felicia A. Schenkel, Michael E. Bowdish, Ross M. Bremner, Robbin G. Cohen, Richard G. Barbers, M. S. Woo, Monica V. Horn, Winfield J. Wells, V. A. Starnes	31
13	Current status of heart and lung transplantation 2001 ·Transplantation Proceedings ·Mark L. Barr	4
14	A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH. 1999 ·The Journal of Heart and Lung Transplantation ·David O. Taylor, Mark L. Barr, Branislav Radovančević, Dale G. Renlund, Robert M. Mentzer, Frank W. Smart, David Tolman, O.H. Frazier, James B. Young, Paul VanVeldhuisen	213
15	Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection 1999 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), (unknown), Charles C. Marboe, Bruce C. Stouch, Vaughn A. Starnes, Mark L. Barr	18
16	A COMPARISON OF THE NEW PRESERVATION SOLUTION CELSIOR TO EURO-COLLINS AND UNIVERSITY OF WISCONSIN SOLUTIONS IN LUNG REPERFUSION INJURY1 1999 ·Transplantation ·(unknown), (unknown), Joseph Carey, Yasushi Sakamaki, Vaughn A. Starnes, Mark L. Barr	43
17	Experience with living-donor lobar transplantation for indications other than cystic fibrosis 1997 ·Journal of Thoracic and Cardiovascular Surgery ·Vaughn A. Starnes, Mark L. Barr, Felicia A. Schenkel, Monica V. Horn, Robbin G. Cohen, (unknown), Winfield J. Wells	46
18	Immunomodulation in Transplantation with Photopheresis 1996 ·Artificial Organs ·Mark L. Barr	16
19	Predictors of survival after repeat heart transplantation 1992 ·The Journal of Heart and Lung Transplantation ·R D Ensley, Sharon Hunt, David O. Taylor, Dale G. Renlund, R L Menlove, Shreekanth V. Karwande, John B. OʼConnell, Mark L. Barr, Robert E. Michler, Jack G. Copeland, Liron Miller	40
20	University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation 1992 ·Journal of Thoracic and Cardiovascular Surgery ·Valluvan Jeevanandam, Mark L. Barr, (unknown), Juan A. Sánchez, (unknown), Felicia A. Schenkel, Charles C. Marboe, Robert E. Michler, Craig R. Smith, Eric A. Rose	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact